Citations

Citations to this article as recorded by  

• Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(2): e238.     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(2): e238.     CrossRef

Citations

Citations to this article as recorded by  

• Reply to correspondence on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Mathias Jachs, Mattias Mandorfer
  Clinical and Molecular Hepatology.2026; 32(1): e106.     CrossRef
• Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(2): e238.     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial 3 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(1): e65.     CrossRef
• Ammonia‐to‐Urea Ratio: A Noninvasive First‐Line Tool for Detecting Clinically Significant Portal Hypertension
  Hatime Ouahbi, Vincent Haghnejad, Alexia Audouy, Maël Silva Rodriguez, Françoise Barbé, Jean‐Louis Guéant, Jean‐Pierre Bronowicki, Abderrahim Oussalah
  JGH Open.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial 2 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(1): e62.     CrossRef
• Global analysis of incidence trends and projections of liver cirrhosis among women of childbearing age: An observational study based on the Global Burden of Disease data
  Pengfei Cheng, Yueyi Sun, Yuanming Qiang, Jushan Wu, Binwei Duan, Guangming Li
  Medicine.2026; 105(23): e48955.     CrossRef
• Revisiting the role of liver cirrhosis in surgical treatment for hepatocellular carcinoma
  Qi Ke, Bujiangcun Luo, Zunyi Zhang, Zhiyong Huang, Erlei Zhang
  Medicine Plus.2025; 2(3): 100096.     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(1): e58.     CrossRef
• Reply to correspondence on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Mathias Jachs, Mattias Mandorfer
  Clinical and Molecular Hepatology.2026; 32(1): e106.     CrossRef
• Correspondence to letter to the editor on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(2): e238.     CrossRef